| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Growing Pains - Signs For Change |
|
Main Subject - Growing Pains - Signs For Change
If you've ever bought shoes for a teenager, then you know first-hand about the pains associated According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product with fast growth. Just when one pair seems barely broken in, it's time for a bigger size! Simi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ar to a parent who can't ignore the urgency of meeting the changing needs of a constantly growi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. g child, the leader of a business in transition also needs to put top priority on addressing th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe "growing pains" - signs that the organization's talent, structure and systems have become outg d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro own. Every organization goes through phases of development. As your business expands, it will ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc tart to feel uncomfortable in its own skin. Customers will continue to expect the next best thi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi g, and in order to anticipate and meet their evolving needs, the organization must be resilient nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically enough, as well as willing and able to transform itself as necessary. Without a plan, things ca and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ just seem to "happen", until one day you find yourself surprised by the stinging reality that ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi hat once fit so well, just doesn't fit right anymore. How do you know when it's time for chang ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e? There are many telltale symptoms of organizational growing pains. While every business in tr dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nsition is unique, take a look at a list of common signs and mentally check off any that are pa cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nfully familiar: ? Lack of a shared vision ? Conflict where there used to be harm tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ny ? Everything is a crisis ? Organization looks to top leader for every decision t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ? Spending too much time putting out fires ? People feel like there aren't enough ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust hours in the day ? Tactical technicians in top leadership ? Meetings are a waste y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products f time ? "Ready, fire, aim!" decision-making ? Sales are growing, but not profits . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de If you’ve checked off more than one and your aim is taking the business to the next level, the elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip its time to replace the growing comfortablenesses of the way it is, and step into bigger shoes tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Focus On White-Collar Crime: Accounting Fraud and Computer Crimes Creates Need; Qualified Investing A Help Desk is a System Designed to Help and Support
|